Considering the relationship between aging, invasion, and metastasis of pancreatic cancer, it is crucial to consider ITGA2 mutation as significant as CDKN2A, BRCA1/2, and PALB2 mutations in the diagnosis and treatment of pancreatic cancer. The gene discussed is ITGA2; the disease is familial pancreatic carcinoma.